Search results
Results From The WOW.Com Content Network
The side effects of bicalutamide, a nonsteroidal antiandrogen (NSAA), including its frequent and rare side effects, have been well-studied and characterized. The most common side effects of bicalutamide monotherapy in men include breast tenderness , breast growth , feminization , demasculinization , and hot flashes .
CLOVES syndrome is a rare overgrowth syndrome with complex vascular anomalies. CLOVES syndrome affects people with various symptoms, ranging from mild fatty soft-tissue tumors to vascular malformations encompassing the spine or internal organs.
Increased gastrin secretion also leads to peptic ulcers in > 50% of MEN 1 patients. Usually the ulcers are multiple or atypical in location, and often bleed, perforate, or become obstructed. Peptic ulcer disease may be intractable and complicated. Among patients presenting with Zollinger-Ellison syndrome, 20 to 60% have MEN 1.
The most common cause is coronary artery disease. Heart attacks are medical emergencies that require immediate medical attention, although some heart attacks can be “silent” and go undetected ...
Zollinger–Ellison syndrome (Z-E syndrome) is a rare disease in which tumors cause the stomach to produce too much acid, resulting in peptic ulcers. Symptoms include abdominal pain and diarrhea . The syndrome is caused by a gastrinoma , a neuroendocrine tumor that secretes a hormone called gastrin . [ 2 ]
Atherosclerosis. Atherosclerosis contributes to about half of all deaths in Western countries, including the United States. Globally, it causes about 10 million deaths per year.. Atherosclerosis ...
Gynecomastia is the most common benign disorder of the male breast tissue and affects 35 percent of men, being most prevalent between the ages of 50 and 69. [ 5 ] [ 9 ] New cases of gynecomastia are common in three age populations: newborns, adolescents, and men older than 50 years. [ 58 ]
Health officials in Europe are investigating Ozempic and the trendy drug’s possible link to an eye-rotting condition that causes blindness. On Dec. 17, the European Medicines Agency announced ...